OneSource Specialty Pharma Limited (BOM:544292)

Market Cap	169.70B +2.8%
Revenue (ttm)	14.19B +30.0%
Net Income	201.02M
EPS	1.75
Shares Out	n/a
PE Ratio	844.18
Forward PE	51.93
Dividend	n/a
Ex-Dividend Date	n/a

Volume	9,293
Average Volume	37,265
Open	1,419.95
Previous Close	1,422.15
Day's Range	1,408.55 - 1,493.00
52-Week Range	1,075.00 - 2,249.65
Beta	n/a
RSI	62.96
Earnings Date	May 7, 2026

About BOM:544292

OneSource Specialty Pharma Limited, a biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biological drug products in various injectable formats in India, Ireland, the United States, and internationally. The company provides end-to-end contract development and manufacturing operations (CDMO) services across various phases of preclinical and clinical development and commercial supply of biologics. It also offers drug-devices, including prefilled syringes, dial and push variable and fixed dose pe...

• Industry: Commercial Physical and Biological Research
• Founded: 2007
• Employees: 1,412
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544292

Financial Performance

In fiscal year 2025, BOM:544292's revenue was 14.45 billion, an increase of 740.43% compared to the previous year's 1.72 billion. Losses were -179.71 million, -95.41% less than in 2024.